How BioPharma Is Using Social Media
•Transferir como PPT, PDF•
4 gostaram•1,163 visualizações
![Today ’s Agenda ,[object Object],[object Object],[object Object],[object Object],[object Object]](data:image/gif;base64,R0lGODlhAQABAIAAAAAAAP///yH5BAEAAAAALAAAAAABAAEAAAIBRAA7)
Recomendados
Recomendados
Mais conteúdo relacionado
Mais procurados
Mais procurados (20)
Semelhante a How BioPharma Is Using Social Media
Semelhante a How BioPharma Is Using Social Media (20)
Último
Último (20)
How BioPharma Is Using Social Media
- 1. How BioPharma Is Using Social Media June 16, 2011 Eileen O ’Brien Director, Search & Innovation
- 4. Traditional Model: Engage Physicians
- 5. Emerging Model: Engage Physicians & Patients
- 8. The Power of Social Media Source: Jake McKee & 90-9-1.com 1% Key Influencers 9% Sharers 90% Audience
- 21. Boehringer Ingelheim: Parkinson ’s Matters
- 28. 1 st Brand Tweet: Levemir
- 30. 1 st Pharma Tweetchat: #RXSave
- 34. Closed Wall = 1 Way Communication
- 36. Comments Allowed: New FB Policy
- 37. Wall With Comments & Company Responses
- 38. Pharma Blogs
- 39. Blog Examples
- 43. Online Health Communities
- 45. Inspire.com
- 46. BioPharma Social Media Best Practices
- 48. Be Willing to Adapt
Notas do Editor
- Connection
- Look at a cautionary tale New drug two possible stories: First and only for preterm birth Or the price spike? $10 to $20 per injection to $1500 per injection Estimate impact on HC system: $30,000 per pregnancy for as many as 140,000 pregnancies per year or $4.2 billion
- Someone started a FB page where patients expressed anger, can ’t tell who started page and their agenda The mainstream media reported that the page existed and had quickly gained fans
- What happened: March of Dimes, who had been worried about purity and consistency of the compounded drug and also had received $1M in donations from KV, praised Makena March of Dimes claimed they were not informed about cost ahead of time and as media backlash continued, they removed support from KV
- What happened: First, members of Congress announced they ’d look at orphan drug determinations The FDA announced they would not enforce exclusivity with legitimate scripts KV shares plummeted more than 30% KV announced a price cut
- UCB
- Look at a cautionary tale New drug two possible stories: First and only for preterm birth Or the price spike? $10 to $20 per injection to $1500 per injection Estimate impact on HC system: $30,000 per pregnancy for as many as 140,000 pregnancies per year or $4.2 billion
- Keep you finger on the pulse of: Regulatory Technology
- Have a plan. Mention Chrysler, etc. Also mention Roche offers guidelines for different platforms on their site: Twitter, Facebook, LinkedIn
- Have a plan. Mention Chrysler, etc. Also mention Roche offers guidelines for different platforms on their site: Twitter, Facebook, LinkedIn